The new safety sanction would be the third for Asheville's Mission Hospital since HCA purchased the hospital in 2019.

The burgeoning of research on the dark triad is perhaps unprecedented in psychology. But a new paper explains why it’s ...

SLB N.V. ( NYSE: SLB) Q3 2025 Earnings Call October 17, 2025 9:30 AM EDT Good morning. My name is Megan, and I'll be your conference operator today. I would like to welcome everyone to the third ...

The Sydney Paralympic was a watershed moment for the Paralympic movement. A quarter of a century later, Kurt Fearnley, Louise ...

Kezar Life Sciences faces FDA delays for AIH drug trials, implements restructuring, and explores strategic alternatives amid ...

Kezar Life Sciences (KZR) shares rallied 47% on Friday afternoon despite analyst downgrades and price target cuts. Jefferies analyst Maury Raycroft downgraded Kezar Life Sciences to ‘Hold’ from ‘Buy’ ...

The biotech provided an update after the stock market closed Thursday, telling investors that it had been unable to align ...

Kezar Life Sciences, Inc. (Nasdaq: KZR, the Company), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today ...

The company reported that as of September 30, 2025, its cash, cash equivalents and marketable securities totaled approximately $90.2 million. Kezar’s Board of Directors has also extended its limited ...

Lite Strategy, Inc. (NASDAQ: LITS) (“Lite Strategy” or “LITS”), the first U.S.-listed public company to adopt Litecoin as its primary reserve asset, joins the digital asset community in celebrating ...

Kezar Life Sciences (KZR) announced regulatory updates and the initiation of a process to explore a full range of strategic alternatives focused ...

This is a clear, candid, and practical explainer for Kenyan Bitcoin and crypto company founders, lawyers, compliance officers ...